Animal models of human atherosclerosis: current progress

A V Poznyak1, Y Y Silaeva2, A N Orekhov1

  • 1Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.

Insights

Atherosclerosis, a leading cause of death, involves complex factors like lipid metabolism, oxidative stress, and inflammation. Genetically modified animal models are crucial for advancing our understanding and developing new therapies for this disease.

Area of Science:

  • Cardiovascular Research
  • Translational Medicine
  • Animal Modeling

Background:

  • Atherosclerosis is a primary global cause of morbidity and mortality, particularly in industrialized nations.
  • Current understanding of atherosclerosis pathogenesis is limited due to its multifactorial nature, involving lipid metabolism, oxidative stress, and inflammation.
  • Effective therapeutic interventions require a deeper comprehension of disease mechanisms.

Purpose of the Study:

  • To review recent advancements in creating and utilizing animal models for atherosclerosis research.
  • To discuss key findings derived from these models in understanding disease progression.
  • To highlight the role of genetically modified animals in modeling complex disease aspects.

Main Methods:

  • Review of current literature on animal models for atherosclerosis.
  • Focus on rodent (mice, rats) and rabbit models.
  • Emphasis on genetically modified animal models.

Main Results:

  • Genetically modified animals offer unprecedented capabilities for modeling atherosclerosis.
  • These models facilitate the study of multifactorial disease processes like altered lipid metabolism, oxidative stress, and chronic inflammation.
  • Significant progress has been made in understanding plaque formation and progression using these advanced models.

Conclusions:

  • Animal models, especially genetically modified ones, are indispensable tools for studying atherosclerosis.
  • These models are critical for identifying effective therapeutic targets and developing novel treatments.
  • Continued development and application of animal models will accelerate progress in combating atherosclerosis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
644
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
361
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259